rheumatoid lung
Recently Published Documents


TOTAL DOCUMENTS

74
(FIVE YEARS 5)

H-INDEX

21
(FIVE YEARS 1)

2020 ◽  
Vol 2020 ◽  
pp. 1-3
Author(s):  
Geetha Wickrematilake

A 65-year-old nonsmoker lady carrying a diagnosis of seropositive erosive rheumatoid arthritis for nine years presented with acute shortness of breath, following a spontaneous pneumothorax while on combination therapy with methotrexate, leflunomide, and tocilizumab. Imaging studies revealed multiple cavitory lung nodules, and a transbronchial lung biopsy favoured a diagnosis of rheumatoid lung nodules. Her initial pathological samples were negative for any infectious cause. A follow-up computerized tomography scan (CT scan) confirmed enlargement of lung nodules with a positive antibody test for aspergillosis which needed antifungal therapy, and currently, her arthritis is managed well with rituximab therapy, sulfasalazine, and hydroxychloroquine.


Author(s):  
Ashish Sharma ◽  
Abhinetri Kasetty ◽  
Ashok Kumar

CHEST Journal ◽  
2019 ◽  
Vol 156 (4) ◽  
pp. A787-A788 ◽  
Author(s):  
Roger Struble ◽  
Vikas Koppurapu ◽  
Matthew McGee ◽  
Spyridon Fortis ◽  
Tayyab Rehman
Keyword(s):  

CHEST Journal ◽  
2019 ◽  
Vol 156 (4) ◽  
pp. A1348
Author(s):  
Alaynna Kears ◽  
Nathan Brewster ◽  
Andrea Soliman ◽  
Stacey Smith ◽  
JAMES ROSS
Keyword(s):  

CHEST Journal ◽  
2018 ◽  
Vol 154 (4) ◽  
pp. 937A
Author(s):  
SWATHI SREE NUTAKKI ◽  
MARILYN FOREMAN ◽  
SHAHLA BARI ◽  
ERIC FLENAUGH
Keyword(s):  

2017 ◽  
Vol 148 (4) ◽  
pp. 188
Author(s):  
Pablo Antonio Zurita Prada ◽  
Claudia Lía Urrego Laurín ◽  
José Manuel Gallardo Romero
Keyword(s):  

2016 ◽  
Vol 47 (3) ◽  
pp. 910-918 ◽  
Author(s):  
Ismini Lasithiotaki ◽  
Ioannis Giannarakis ◽  
Eliza Tsitoura ◽  
Katerina D. Samara ◽  
George A. Margaritopoulos ◽  
...  

In this study we investigated the implication of NLRP3 inflammasomes in the pathogenesis of idiopathic pulmonary fibrosis (IPF) and rheumatoid arthritis–usual interstitial pneumonia (RA-UIP).NLRP3 inflammasome activation at baseline and following stimulation with lipopolysaccharide/ATP was evaluated by measuring interleukin (IL)-1β and IL-18 levels released in the bronchoalveolar lavage fluid (BALF) fluid and by cultures of BALF cells. IL-1β and IL-18 levels were significantly elevated in the BALF and BALF macrophage cultures from RA-UIP patients, consistent with pre-existing inflammasome activation in these patients. In contrast, in IPF, BALF levels of IL-1β were significantly less elevated relative to RA-UIP and IL-18 was lower than controls. Furthermore, upon inflammasome stimulation, IPF BALF macrophage cultures failed to upregulate IL-1β and partly IL-18 secretion, in contrast to controls, which showed robust IL-1β and IL-18 upregulation. Interestingly, RA-UIP BALF cell cultures treated with lipopolysaccharide/ATP showed a potent stimulation of IL-18 secretion but not IL-1β, the latter being already elevated in the unstimulated cultures, while examination of the intracellular IL-1β levels in RA-UIP BALF cells upon NLRP3 inflammasome stimulation showed a significant upregulation of IL-1β suggesting the NLRP3 pathway could be further activated.Taken together, our results suggest distinct inflammasome activation profiles between autoimmune and idiopathic lung fibrosis.


Sign in / Sign up

Export Citation Format

Share Document